Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 179 of 1,261
  1. US 11717565

    Recombinant BCG overexpressing phoP-phoR

    LTD. Β· Granted Aug 8, 2023 Β· Expires Aug 3, 2043

    granted
  2. US 11718647

    Virus-like particles and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Aug 8, 2023 Β· Expires Aug 3, 2043

    granted
  3. US 11717573

    Methods and compositions for the treatment of cancer

    SOUTH DAKOTA BOARD OF REGENTS Β· Granted Aug 8, 2023 Β· Expires Aug 3, 2043

    granted
  4. US 11718612

    Inhibitors of receptor interacting protein kinase I for the treatment of disease

    The Board of Regents of the University of Texas System Β· Granted Aug 8, 2023 Β· Expires Aug 3, 2043

    granted
  5. US 11717547

    Compositions and methods for the treatment of autosomal recessive congenital ichthyosis

    Krystal Biotech, Inc. Β· Granted Aug 8, 2023 Β· Expires Aug 3, 2043

    granted
  6. US 11717576

    Antibody-immune agonist conjugate and applications thereof

    GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. Β· Granted Aug 8, 2023 Β· Expires Aug 3, 2043

    granted
  7. US 11717480

    Extracellular vesicles and methods and uses thereof

    The Regents of the University of California Β· Granted Aug 8, 2023 Β· Expires Aug 3, 2043

    granted
  8. KR 20230116805

    κ°€λ„ν…Œλ¦¬λŒ 제쑰λ₯Ό μœ„ν•œ 제쑰 방법

    BRACCO IMAGING SPA [IT] Β· Granted Aug 4, 2023 Β· Expires Jul 30, 2043

    granted
  9. US 11712483

    Activatable membrane-interacting peptides and methods of use

    The Regents of the University of California Β· Granted Aug 1, 2023 Β· Expires Jul 27, 2043

    granted
  10. US 11713311

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited Β· Granted Aug 1, 2023 Β· Expires Jul 27, 2043

    granted
  11. US 11713324

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. Β· Granted Aug 1, 2023 Β· Expires Jul 27, 2043

    granted
  12. US 11713922

    Target residual moisture content for lyophilized drug product

    REGENERON PHARMACEUTICALS, INC. Β· Granted Aug 1, 2023 Β· Expires Jul 27, 2043

    granted
  13. US 11712441

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. Β· Granted Aug 1, 2023 Β· Expires Jul 27, 2043

    granted
  14. US 11713353

    Single-domain antibodies and variants thereof against PD-1

    Nanjing Legend Biotech Co., Ltd Β· Granted Aug 1, 2023 Β· Expires Jul 27, 2043

    granted
  15. US 11713292

    Treatment of cataplexy

    AXSOME MALTA LTD. Β· Granted Aug 1, 2023 Β· Expires Jul 27, 2043

    granted
  16. US 11712418

    Chemoembolization agents

    The Regents of the University of California Β· Granted Aug 1, 2023 Β· Expires Jul 27, 2043

    granted
  17. US 11712474

    Reduction of post-surgery cancer metastasis by combination of cannabidiol and NR2F6 inhibition

    Regen Biopharma, Inc. Β· Granted Aug 1, 2023 Β· Expires Jul 27, 2043

    granted
  18. US 11712461

    Long-acting polypeptide composition for treating atrial fibrillation and its application

    The First Affiliated Hospital of Xi'an Jiaotong University Β· Granted Aug 1, 2023 Β· Expires Jul 27, 2043

    granted
  19. US 11712427

    Method for increasing serum adiponectin for treatment and reduction of the risk of cardiovascular, vascular, and related diseases

    FIRST FRUITS BUSINESS MINISTRY, LLC Β· Granted Aug 1, 2023 Β· Expires Jul 27, 2043

    granted
  20. US 11713446

    Processes for generating TIL products enriched for tumor antigen-specific T-cells

    Iovance Biotherapeutics, Inc. Β· Granted Aug 1, 2023 Β· Expires Jul 27, 2043

    granted
  21. US 11713461

    Treatment of decreased bone mineral density with zinc and ring finger 3 (ZNRF3) inhibitors

    REGENERON PHARMACEUTICALS, INC. Β· Granted Aug 1, 2023 Β· Expires Jul 27, 2043

    granted
  22. US 11714089

    Combination of markers for diagnosing cancer

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center Β· Granted Aug 1, 2023 Β· Expires Jul 27, 2043

    granted
  23. US 11713462

    Modulation of GYS1 expression

    Ionis Pharmaceuticals, Inc. Β· Granted Aug 1, 2023 Β· Expires Jul 27, 2043

    granted
  24. US 11712460

    Methods of treating chronic disorders with complement inhibitors

    Apellis Pharmaceuticals, Inc. Β· Granted Aug 1, 2023 Β· Expires Jul 27, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.